Recently, LVMH Recherche, the beauty R&D division of LVMH, has announced a strategic partnership with Integrated Biosciences, a pioneering company in AI-driven biotechnology. The collaboration aims to harness advanced artificial intelligence and optogenetics platforms to identify novel molecular entities that target aging, setting the stage for cutting-edge skin youth and beauty products.
Integrated Biosciences will deploy its proprietary AI technology to virtually screen hundreds of thousands of molecules, identifying chemical compounds capable of effectively modulating age-related biological phenotypes. This innovative approach combines the power of deep learning with scientific rigor to revolutionize the discovery of bioactive molecules.
Bruno Bavouzet, President of LVMH Recherche, emphasized the groundbreaking nature of the partnership: “This represents a unique opportunity to evaluate thousands of potential bioactives concurrently, revolutionizing the pace of our research for the benefit of all our brands, amongst them our flagship – Maison Parfums Christian Dior. By combining our skin research expertise with their AI and aging research, we are taking a decisive step in understanding and molecularly addressing age-related cellular pathways.”
Integrated Biosciences, founded by leading scientists from MIT, Harvard University, and the University of California Santa Barbara, has earned recognition for its work in the AI-driven discovery of anti-aging chemical entities, including compounds that selectively target and clear senescent “zombie” cells.
Felix Wong, Ph.D., CEO and co-founder of Integrated Biosciences, shared his enthusiasm: “We are excited to integrate our proprietary technology platform with LVMH Recherche’s scientific programs, leveraging our ability to control biological stress responses to develop novel, targeted bioactive molecules. Our combined efforts have the potential to unlock biologically functional products that could transform how people age.”
